BIOA Stock Analysis: Buy, Sell, or Hold?
BIOA - BioAge Labs, Inc. Common Stock
$25.10
0.84 (3.46%)
▲
5d:
+10.96%
30d:
+51.75%
90d:
+41.57%
WAIT
LOW Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Get Alerted When BIOA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: BIOA is 21.5% above its trading range ($20.66). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: BIOA is 21.5% above its trading range ($20.66). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: BIOA is currently trading at $25.10, which is considered extended relative to its 30-day fair value range of $15.52 to $20.66.
Technical Outlook: Technically, BIOA is showing sideways momentum. The price is approaching resistance at $25.80. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.5% recently.
Market Sentiment: BIOA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $49.50 (+97.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BIOA is showing sideways momentum. The price is approaching resistance at $25.80. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.5% recently.
Market Sentiment: BIOA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $49.50 (+97.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$15.52 -
$20.66
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
Protect Your Profits
BIOA is technically overbought (RSI 75). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+21.5% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.5%)
- BULLISH: Trading 97.2% below Wall St target ($49.50)
- WARNING: Recommendation downgraded due to 21.5% overvaluation
Trading Range Analysis
30-Day Trading Range
$15.52 -
$20.66
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$19.32
Resistance Level
$25.80
Current Trend
Sideways
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-12.18
Wall Street Target
$49.50
(+97.2%)
Revenue Growth (YoY)
91.0%
Share & Embed Analysis
Last updated: July 02, 2026 9:42 PM ET
Data refreshes hourly during market hours. Next update: 10:42 PM
Data refreshes hourly during market hours. Next update: 10:42 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BIOA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Paul D Rubin
SELL
7433 shares
2026-02-02
Dov A Md Goldstein
SELL
27000 shares
2026-01-13
Kristen Fortney
SELL
233107 shares
2026-01-13
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$194 | 62 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$105 | 63 BUY |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$665 | 61 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$125 | 54 HOLD |
|
HCM
HUTCHMED DRC |
STRONG BUY
14 analysts |
$23 | 60 HOLD |
Advanced BIOA Option Strategies
Professional options setups generated by AI based on today's BIOA price and gamma walls.
